 | • レポートコード：MRC2Q12-16789 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、潜在性結核感染検出のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 潜在性結核感染検出のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 潜在性結核感染検出の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 潜在性結核感染検出のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの潜在性結核感染検出の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の潜在性結核感染検出の売上および2028年までの予測に焦点を当てています。 潜在性結核感染検出のグローバル主要企業には、Abbott、QIAGEN、F. Hoffmann-La Roche Ltd、Sanofi、Oxford Immunotec USA、ARKRAY, Inc.、bioMérieux SAなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 潜在性結核感染検出市場は、タイプとアプリケーションによって区分されます。世界の潜在性結核感染検出市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 ツベルクリン皮膚反応、インターフェロンガンマ放出測定装置 【アプリケーション別セグメント】 診断研究所、病院・クリニック、学術・研究機関 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 潜在性結核感染検出製品概要 - タイプ別市場（ツベルクリン皮膚反応、インターフェロンガンマ放出測定装置） - アプリケーション別市場（診断研究所、病院・クリニック、学術・研究機関） - 調査の目的 ・エグゼクティブサマリー - 世界の潜在性結核感染検出販売量予測2017-2028 - 世界の潜在性結核感染検出売上予測2017-2028 - 潜在性結核感染検出の地域別販売量 - 潜在性結核感染検出の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別潜在性結核感染検出販売量 - 主要メーカー別潜在性結核感染検出売上 - 主要メーカー別潜在性結核感染検出価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（ツベルクリン皮膚反応、インターフェロンガンマ放出測定装置） - 潜在性結核感染検出のタイプ別販売量 - 潜在性結核感染検出のタイプ別売上 - 潜在性結核感染検出のタイプ別価格 ・アプリケーション別市場規模（診断研究所、病院・クリニック、学術・研究機関） - 潜在性結核感染検出のアプリケーション別販売量 - 潜在性結核感染検出のアプリケーション別売上 - 潜在性結核感染検出のアプリケーション別価格 ・北米市場 - 北米の潜在性結核感染検出市場規模（タイプ別、アプリケーション別） - 主要国別の潜在性結核感染検出市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの潜在性結核感染検出市場規模（タイプ別、アプリケーション別） - 主要国別の潜在性結核感染検出市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の潜在性結核感染検出市場規模（タイプ別、アプリケーション別） - 主要国別の潜在性結核感染検出市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の潜在性結核感染検出市場規模（タイプ別、アプリケーション別） - 主要国別の潜在性結核感染検出市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの潜在性結核感染検出市場規模（タイプ別、アプリケーション別） - 主要国別の潜在性結核感染検出市場規模（トルコ、サウジアラビア） ・企業情報 Abbott、QIAGEN、F. Hoffmann-La Roche Ltd、Sanofi、Oxford Immunotec USA、ARKRAY, Inc.、bioMérieux SA ・産業チェーン及び販売チャネル分析 - 潜在性結核感染検出の産業チェーン分析 - 潜在性結核感染検出の原材料 - 潜在性結核感染検出の生産プロセス - 潜在性結核感染検出の販売及びマーケティング - 潜在性結核感染検出の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 潜在性結核感染検出の産業動向 - 潜在性結核感染検出のマーケットドライバー - 潜在性結核感染検出の課題 - 潜在性結核感染検出の阻害要因 ・主な調査結果 |
The main ways to diagnose LTBI are by placing a tuberculin skin test (TST) on the forearm or by getting a TB blood test, in addition to obtaining a chest radiograph (x-ray) if either one of these tests is positive. One-third of the world’s population has LTBI. The TB germs are dormant (asleep) in the body.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Latent Tuberculosis Infection Detection estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Latent Tuberculosis Infection Detection is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Latent Tuberculosis Infection Detection is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Latent Tuberculosis Infection Detection is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Latent Tuberculosis Infection Detection include Abbott, QIAGEN, F. Hoffmann-La Roche Ltd, Sanofi, Oxford Immunotec USA, ARKRAY, Inc. and bioMérieux SA, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Latent Tuberculosis Infection Detection companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Latent Tuberculosis Infection Detection market. Further, it explains the major drivers and regional dynamics of the global Latent Tuberculosis Infection Detection market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Abbott
QIAGEN
F. Hoffmann-La Roche Ltd
Sanofi
Oxford Immunotec USA
ARKRAY, Inc.
bioMérieux SA
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Latent Tuberculosis Infection Detection Segment by Type
Tuberculin Skin Test
Interferon Gamma Release Assays
Latent Tuberculosis Infection Detection Segment by Application
Diagnostic Laboratories
Hospitals/Clinics
Academic & Research Institutions
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Latent Tuberculosis Infection Detection market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Latent Tuberculosis Infection Detection market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Latent Tuberculosis Infection Detection, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Latent Tuberculosis Infection Detection, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Latent Tuberculosis Infection Detection revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Latent Tuberculosis Infection Detection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Latent Tuberculosis Infection Detection revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbott, QIAGEN, F. Hoffmann-La Roche Ltd, Sanofi, Oxford Immunotec USA, ARKRAY, Inc. and bioMérieux SA, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Latent Tuberculosis Infection Detection in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Latent Tuberculosis Infection Detection companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Latent Tuberculosis Infection Detection revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Latent Tuberculosis Infection Detection Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Tuberculin Skin Test
1.2.3 Interferon Gamma Release Assays
1.3 Market by Application
1.3.1 Global Latent Tuberculosis Infection Detection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals/Clinics
1.3.4 Academic & Research Institutions
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Latent Tuberculosis Infection Detection Market Perspective (2017-2028)
2.2 Latent Tuberculosis Infection Detection Growth Trends by Region
2.2.1 Latent Tuberculosis Infection Detection Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Latent Tuberculosis Infection Detection Historic Market Size by Region (2017-2022)
2.2.3 Latent Tuberculosis Infection Detection Forecasted Market Size by Region (2023-2028)
2.3 Latent Tuberculosis Infection Detection Market Dynamics
2.3.1 Latent Tuberculosis Infection Detection Industry Trends
2.3.2 Latent Tuberculosis Infection Detection Market Drivers
2.3.3 Latent Tuberculosis Infection Detection Market Challenges
2.3.4 Latent Tuberculosis Infection Detection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Latent Tuberculosis Infection Detection Players by Revenue
3.1.1 Global Top Latent Tuberculosis Infection Detection Players by Revenue (2017-2022)
3.1.2 Global Latent Tuberculosis Infection Detection Revenue Market Share by Players (2017-2022)
3.2 Global Latent Tuberculosis Infection Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Latent Tuberculosis Infection Detection Revenue
3.4 Global Latent Tuberculosis Infection Detection Market Concentration Ratio
3.4.1 Global Latent Tuberculosis Infection Detection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Latent Tuberculosis Infection Detection Revenue in 2021
3.5 Latent Tuberculosis Infection Detection Key Players Head office and Area Served
3.6 Key Players Latent Tuberculosis Infection Detection Product Solution and Service
3.7 Date of Enter into Latent Tuberculosis Infection Detection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Latent Tuberculosis Infection Detection Breakdown Data by Type
4.1 Global Latent Tuberculosis Infection Detection Historic Market Size by Type (2017-2022)
4.2 Global Latent Tuberculosis Infection Detection Forecasted Market Size by Type (2023-2028)
5 Latent Tuberculosis Infection Detection Breakdown Data by Application
5.1 Global Latent Tuberculosis Infection Detection Historic Market Size by Application (2017-2022)
5.2 Global Latent Tuberculosis Infection Detection Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Latent Tuberculosis Infection Detection Market Size (2017-2028)
6.2 North America Latent Tuberculosis Infection Detection Market Size by Type
6.2.1 North America Latent Tuberculosis Infection Detection Market Size by Type (2017-2022)
6.2.2 North America Latent Tuberculosis Infection Detection Market Size by Type (2023-2028)
6.2.3 North America Latent Tuberculosis Infection Detection Market Share by Type (2017-2028)
6.3 North America Latent Tuberculosis Infection Detection Market Size by Application
6.3.1 North America Latent Tuberculosis Infection Detection Market Size by Application (2017-2022)
6.3.2 North America Latent Tuberculosis Infection Detection Market Size by Application (2023-2028)
6.3.3 North America Latent Tuberculosis Infection Detection Market Share by Application (2017-2028)
6.4 North America Latent Tuberculosis Infection Detection Market Size by Country
6.4.1 North America Latent Tuberculosis Infection Detection Market Size by Country (2017-2022)
6.4.2 North America Latent Tuberculosis Infection Detection Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Latent Tuberculosis Infection Detection Market Size (2017-2028)
7.2 Europe Latent Tuberculosis Infection Detection Market Size by Type
7.2.1 Europe Latent Tuberculosis Infection Detection Market Size by Type (2017-2022)
7.2.2 Europe Latent Tuberculosis Infection Detection Market Size by Type (2023-2028)
7.2.3 Europe Latent Tuberculosis Infection Detection Market Share by Type (2017-2028)
7.3 Europe Latent Tuberculosis Infection Detection Market Size by Application
7.3.1 Europe Latent Tuberculosis Infection Detection Market Size by Application (2017-2022)
7.3.2 Europe Latent Tuberculosis Infection Detection Market Size by Application (2023-2028)
7.3.3 Europe Latent Tuberculosis Infection Detection Market Share by Application (2017-2028)
7.4 Europe Latent Tuberculosis Infection Detection Market Size by Country
7.4.1 Europe Latent Tuberculosis Infection Detection Market Size by Country (2017-2022)
7.4.2 Europe Latent Tuberculosis Infection Detection Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Latent Tuberculosis Infection Detection Market Size (2017-2028)
8.2 Asia-Pacific Latent Tuberculosis Infection Detection Market Size by Type
8.2.1 Asia-Pacific Latent Tuberculosis Infection Detection Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Latent Tuberculosis Infection Detection Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Latent Tuberculosis Infection Detection Market Share by Type (2017-2028)
8.3 Asia-Pacific Latent Tuberculosis Infection Detection Market Size by Application
8.3.1 Asia-Pacific Latent Tuberculosis Infection Detection Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Latent Tuberculosis Infection Detection Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Latent Tuberculosis Infection Detection Market Share by Application (2017-2028)
8.4 Asia-Pacific Latent Tuberculosis Infection Detection Market Size by Region
8.4.1 Asia-Pacific Latent Tuberculosis Infection Detection Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Latent Tuberculosis Infection Detection Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Latent Tuberculosis Infection Detection Market Size (2017-2028)
9.2 Latin America Latent Tuberculosis Infection Detection Market Size by Type
9.2.1 Latin America Latent Tuberculosis Infection Detection Market Size by Type (2017-2022)
9.2.2 Latin America Latent Tuberculosis Infection Detection Market Size by Type (2023-2028)
9.2.3 Latin America Latent Tuberculosis Infection Detection Market Share by Type (2017-2028)
9.3 Latin America Latent Tuberculosis Infection Detection Market Size by Application
9.3.1 Latin America Latent Tuberculosis Infection Detection Market Size by Application (2017-2022)
9.3.2 Latin America Latent Tuberculosis Infection Detection Market Size by Application (2023-2028)
9.3.3 Latin America Latent Tuberculosis Infection Detection Market Share by Application (2017-2028)
9.4 Latin America Latent Tuberculosis Infection Detection Market Size by Country
9.4.1 Latin America Latent Tuberculosis Infection Detection Market Size by Country (2017-2022)
9.4.2 Latin America Latent Tuberculosis Infection Detection Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Latent Tuberculosis Infection Detection Market Size (2017-2028)
10.2 Middle East & Africa Latent Tuberculosis Infection Detection Market Size by Type
10.2.1 Middle East & Africa Latent Tuberculosis Infection Detection Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Latent Tuberculosis Infection Detection Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Latent Tuberculosis Infection Detection Market Share by Type (2017-2028)
10.3 Middle East & Africa Latent Tuberculosis Infection Detection Market Size by Application
10.3.1 Middle East & Africa Latent Tuberculosis Infection Detection Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Latent Tuberculosis Infection Detection Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Latent Tuberculosis Infection Detection Market Share by Application (2017-2028)
10.4 Middle East & Africa Latent Tuberculosis Infection Detection Market Size by Country
10.4.1 Middle East & Africa Latent Tuberculosis Infection Detection Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Latent Tuberculosis Infection Detection Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Latent Tuberculosis Infection Detection Introduction
11.1.4 Abbott Revenue in Latent Tuberculosis Infection Detection Business (2017-2022)
11.1.5 Abbott Recent Developments
11.2 QIAGEN
11.2.1 QIAGEN Company Details
11.2.2 QIAGEN Business Overview
11.2.3 QIAGEN Latent Tuberculosis Infection Detection Introduction
11.2.4 QIAGEN Revenue in Latent Tuberculosis Infection Detection Business (2017-2022)
11.2.5 QIAGEN Recent Developments
11.3 F. Hoffmann-La Roche Ltd
11.3.1 F. Hoffmann-La Roche Ltd Company Details
11.3.2 F. Hoffmann-La Roche Ltd Business Overview
11.3.3 F. Hoffmann-La Roche Ltd Latent Tuberculosis Infection Detection Introduction
11.3.4 F. Hoffmann-La Roche Ltd Revenue in Latent Tuberculosis Infection Detection Business (2017-2022)
11.3.5 F. Hoffmann-La Roche Ltd Recent Developments
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Latent Tuberculosis Infection Detection Introduction
11.4.4 Sanofi Revenue in Latent Tuberculosis Infection Detection Business (2017-2022)
11.4.5 Sanofi Recent Developments
11.5 Oxford Immunotec USA
11.5.1 Oxford Immunotec USA Company Details
11.5.2 Oxford Immunotec USA Business Overview
11.5.3 Oxford Immunotec USA Latent Tuberculosis Infection Detection Introduction
11.5.4 Oxford Immunotec USA Revenue in Latent Tuberculosis Infection Detection Business (2017-2022)
11.5.5 Oxford Immunotec USA Recent Developments
11.6 ARKRAY, Inc.
11.6.1 ARKRAY, Inc. Company Details
11.6.2 ARKRAY, Inc. Business Overview
11.6.3 ARKRAY, Inc. Latent Tuberculosis Infection Detection Introduction
11.6.4 ARKRAY, Inc. Revenue in Latent Tuberculosis Infection Detection Business (2017-2022)
11.6.5 ARKRAY, Inc. Recent Developments
11.7 bioMérieux SA
11.7.1 bioMérieux SA Company Details
11.7.2 bioMérieux SA Business Overview
11.7.3 bioMérieux SA Latent Tuberculosis Infection Detection Introduction
11.7.4 bioMérieux SA Revenue in Latent Tuberculosis Infection Detection Business (2017-2022)
11.7.5 bioMérieux SA Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer